General topic: Applications of transgenic rabbits in biomedical research - Based on literature search

World Rabbit Science

Volumn 18, Issue 3, 2010, Pages 159-167

  Zhao, S ^a   Wei, K ^a   Yu, Q ^a   Li, Y ^a   Cheng, F ^a   Wang, Y ^a   Yang, P ^a   Fan, J ^b   Liu, E ^a  

^a MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

^b UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Atherosclerosis; Biomedical research; Bioreactor; Transgenic rabbits

Indexed keywords

MAMMALIA; MUS; ORYCTOLAGUS CUNICULUS;

EID: 84864705689     PISSN: 12575011     EISSN: None     Source Type: Journal    
DOI: 10.4995/wrs.2010.7279     Document Type: Article

References (59)

1. Araki M., Fan J., Challan M., Bensadoun A., Yamada N., Honda K., Watanabe T. 2000. Transgenic rabbits expressing human lipoprotein lipase. Cytotechnology, 33: 93-99.
2. Baranyi M., Hiripi L., Szabó L., Catunda A P., Harsinyi I., Komáromy P., Bosze Z. 2007. Isolation and some effects of functional, lowphenylalanine kappa-casein expressed in the milk of transgenic rabbits. J Biotechnol., 128:383-392. (Pubitemid 46091810)
3. Bijvoet A.G., Van Hirtum H., Kroos M.A., Van de Kamp E.H, Schoneveld O., Visser P., Brakenhoff J.P., Weggeman M., van Corven EJ., Van der Ploeg A.T., Reuser AJ. 1999. Human acid alpha-glucosidase from rabbit milk has therapeutic effect in mice with glycogen storage disease type II. Hum. Mol. Genet., 8: 2145-2153.
4. Bodrogi L., Brands R., Raaben W., Seinen W., Baranyi M., Fiechter D., Bosze Z. 2006. High level expression of tissue-nonspecific alkaline phosphatase in the milk of transgenic rabbits. Transgenic Res., 15: 627-636. (Pubitemid 44401442)
5. Bosze Z., Hiripi L., Carnwath J.W., Niemann H. 2003. The transgenic rabbit as model for human diseases and as a source of biologically active recombinant proteins. Transgenic Res., 12: 541-553. (Pubitemid 37292442)
6. Bosze Z., Houdebine L.M. 2006. Application of rabbits in biomedical research: A review. World Rabbit Sci., 14:1-14. (Pubitemid 44114296)
7. Brem G., Besenfelder U., Zinovieva N., Seregi J., Solti L., Haul P. 1995. Mammary gland-specific expression of chymosin constructs in transgenic rabbits. Theriogenology., 43: 175.
8. Brem G., Hartl P., Besenfelder U., Wolf E., Zinovieva N., Pfaller R. 1994. Expression of synthetic cDNA sequences encoding human insulin-like growth factor-1 (IGF-I) in the mammary gland of transgenic rabbits. Gene., 149:351-355. (Pubitemid 24361930)
9. Brousseau M.E., Hoeg J.M. 1999. Transgenic rabbits as models for atherosclerosis research. J Lipid Res., 40:365-375. (Pubitemid 29116139)
10. Brunner M., Peng X., Liu G.X., Ren X.Q., Ziv O., Choi B.R., Mathur R., Hajjiri M., Odening K.E., Steinberg E., Folco EJ., Pringa E., Centracchio J., Macharzina R.R., Donahay T., Schofield L., Rana N., Kirk M., Mitchell G.F, Poppas A., Zehender M., Koren G. 2008. Mechanisms of cardiac arrhythmias and sudden death in transgenic rabbits with long QT syndrome. J. Clin. Invesl., 118: 2246-2259 (Pubitemid 351872342)
11. Buhler TA., Bruyere T., Went D.F, Stranzinger G., Burki K. 1990. Rabbit beta-casein promoter directs secretion of human interleukin-2 into the milk of transgenic rabbits. Bio-Technol., 8: 140-143.
12. Chrenek P., Ryban L., Vetr H., Makarevich A.V, Uhrin P., Paleyanda R.K., Binder B.R. 2007. Expression of recombinant human factor VIlI in milk of several generations of transgenic rabbits. Transgenic Res., 16. 353-361. (Pubitemid 46643863)
13. Coulibaly S., Besenfelder U-, Fleischmann M., Zinovieva N, Grossmann A., Wozny M., Bartke I., Togel M., Muller M., Brem G. 1999. Human nerve growth factor beta (hNGF-beta): mammary gland specific expression and production in transgenic rabbits. FEBS LeIl, 444.111-116.
14. Dragin S., Chrastinova L., Makarevich A., Chrenek P. 2005. Production of recombinant human protein C in the milk of transgenic rabbits from the F3 generation. Folia Biol. (Krakow)., 53: 129-132. (Pubitemid 41819684)
15. Duverger N., Viglietta C., Berthou L., Emmanuel F., Tailleux A., Parmentier-Nihoul L., Laine B., Fievet C., Castro G., Fruchart J.C, Houbebine L.M., Denefie P. 1996b. Transgenic rabbits expressing human apolipoprotein A-I in the liver. Arlerioscl. Throm. Vase, 16. 1424-1429. (Pubitemid 26427594)
16. Duverger, N., Kruth, H., Emmanuel, F., Caillaud, J. M., Viglietta, C., Castro, G., Tailleux, A., Fievet, C., Fruchart, J. C., Houdebine, L.M., Denefie, P. 1996. Inhibition of atherosclerosis development in cholesterol-fed human apolipoprotein A-I-transgenic rabbits. Circulation, 94-713-717.
17. Ebbert J.O., Dupras D.M., Erwin P.J. 2003. Searching the medical literature using PubMed: a tutorial. Mayo Clin. Proc, 78:87-91. (Pubitemid 36033964)
18. Fan J., Wang J., Bensadoun A., Lauer S.J., Dang Q., Mahley R.W., Taylor J.M. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc Natl. Acad. Sci. U. S. A., 91: 8724-8728. (Pubitemid 24273737)
19. Fan J., McCormick S P., Krauss R.M, Taylor S., Quan R., Taylor J.M., Young S.G. 1995. Overexpression of human apolipoprotein B-100 in transgenic rabbits results in increased levels of LDL and decreased levels of HDL. Arterioscl. Throm.Vasc, 15:1889-1899.
20. Fan J., Ji Z., Huang Y., de Silva H., Sanan D., Mahley R.W., Innerarity TL., Taylor J.M. 1998. Increased expression of apolipoprotein E in transgenic rabbits results in reduced levels of very low density lipoproteins and an accumulation of low density lipoproteins in plasma. J Clin. Invest., 101: 2151-2164. (Pubitemid 28244099)
21. Fan J., Araki M., Wu L., Challan M., Shimoyamada H., Lawn R.M., Kakuta H., Shikama H., Watanabe T. 1999a. Assembly of lipoprotein (a) in transgenic rabbits expressing human apolipoprotein (a). Biochem. Biophys. Res. Commun., 255: 639-644. (Pubitemid 29294851)
22. Fan J., Challah M., Watanabe T. 1999b. Transgenic rabbit models for biomedical research: current status, basic methods and future perspectives. Pathol. Int., 49: 583-594. (Pubitemid 29461208)
23. Fan J., Watanabe T. 2003. Transgenic rabbits as therapeutic protein bioreactors and human disease models. Pharmacol. Therapeut., 99: 261-282. (Pubitemid 37311195)
24. Fan J., Wang X., Wu L., Matsumoto S.I., Liang J., Koike T, Ichikawa T, Sun H., Shikama H., Sasaguri Y, Watanabe T. 2004. Macrophagespecific overexpression of human matrix metalloproteinase-12 in transgenic rabbits. Transgenic Res., 13: 261-269. (Pubitemid 39048106)
25. Galet C., Le Bourhis CM., Chopineau M., Le Griec G., Perrin A., Magallon T., Attal J., Viglietta C., Houdebine L.M., Guillou F. 2000. Expression of a single betaalpha chain protein of equine LH/ CG in milk of transgenic rabbits and its biological activity. Mol. Cell. Endocrinol, 174- 31-40.
26. Graur D., Duret L., Gouy M. 1996. Phylogenetic position of the order Lagomorpha (rabbits, hares and allies). Nature, 379- 333-335.
27. Hammer R.E., Pursel VG., Rexroad CE., Wall RJ., Bolt DJ., Ebert K.M., Palmiter R.D., Brinster R L. 1985. Production of transgenic rabbits, sheep and pigs by microinjection. Nature, 315.680-683.
28. Hiripi L., Makovics F., Halter R., Baranyi M., Paul D., Carnwath J.W., Bösze Z., Niemann H. 2003. Expression of active human blood clotting factor VlII in mammary gland of transgenic rabbits. DNA Cell. Biol., 22: 41-45. (Pubitemid 36570517)
29. Hoeg J.M., Santamarina-Fojo S., Berard A.M, Cornhill JR, Herderick E.E., Feldman S H., Haudenschild CC., Vaisman B.L., Hoyt R.F, Demosky SJ., Kauffman R.D., Hazel CM., Marcovina S.M., Brewer H.B. 1996. Overexpression of lecithin:cholesterol acyltransferase in transgenic rabbits prevents diet-induced atherosclerosis. Proc. Natl. Acad Sci. U. S. A., 93:11448-11453.
30. Houdebine L.M., Fan J. 2009. Rabbit Biotechnology: Rabbit genomics, transgenesis, cloning and models. Springer Dordrecht Heidelberg London New York
31. Huang Y.D, Schwendner S.W., Rall S.C, Sanan D.A., Mahley R.W. 1997. Apolipoprotein E2 transgenic rabbits - Modulation of the type III hyperlipoproteineraic phenotype by estrogen and occurrence of spontaneous atherosclerosis. J. Biol. Chem., 272:22685-22694. (Pubitemid 27386085)
32. James J., Sanbe A., Yager K., Martin L., Klevitsky R., Robbins J. 2000. Genetic manipulation of the rabbit heart via transgenesis. Circulation, 101: 1715-1721. (Pubitemid 30196633)
33. James J., Zhang Y, Wright K., Witt S., Glascock E., Osinska H, Klevitsky R., Martin L., Yager K., Sanbe A., Robbins J. 2002. Transgenic rabbits expressing mutant essential light chain do not develop hypertrophic cardiomyopathy. J. MoI. Cell. Cardiol., 34: 873-882. (Pubitemid 35205188)
34. Kavinsky CJ., Umeda P.K., Levin J.E., Sinha A.M., Nigro J.M., Jakovcic S., Rabinowitz M. 1984. Analysis of cloned mRNA sequences encoding subfragment 2 and part of subfragment 1 of alpha and beta-myosin heavy chains of rabbit heart. J. Biol. Chem., 259: 2775-2781. (Pubitemid 14163139)
35. Khodarovich IuM., Vorob'eva N E., Mezina M.N., Piniugina M.V, Prokofev M I, Larionov O.A. 2008. [Expression of human interferon beta in the mammary gland of transgenic rabbits.] Bioorg Khim., 34:185-193.
36. Kitajima S., Liu E., Morimoto M., Koike T, Yu Y, Watanabe T, Imagawa S., Fan J. 2005. Transgenic rabbits with increased VEGF expression develop hemangiomas in the liver: a new model for Kasabach-Merritt syndrome. Lab. Invest., 85:1517-1527. (Pubitemid 41662336)
37. Koles K., van Berkel P.H., Pieper RR., Nuijens J.H., Mannesse M L., Vliegenthart J.F, Kamerling J.P. 2004. N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. Glycobiology, 14:51-64 (Pubitemid 38159408)
38. Korhonen V.P., Tolvanen M., Hyttinen J.M., Uusioukari M., Sinervirta R., Alhonen L., Jauhiainen M., Janne O.A., Janne J. 1997. Expression of bovine beta-lactoglobulin human erythropoietin fusion protein in the milk of transgenic mice and rabbits. Eur J. Biochem., 245: 482-489. (Pubitemid 27171276)
39. Limonta J.M., Castro FO., Martinez R., Puentes P., Ramos B., Aguilar A., Lleonart R.L., de la Fuente J. 1995. Transgenic rabbits as bioreactors for the production of human growth hormone. J Biotechnol., 40: 49-58.
40. Lubon H., Palmer C. 2000. Transgenic animal bioreactors-where we are. Transgenic Res., 9: 301-304.
41. Marian AJ., Wu Y, Lim D.S., McCluggage M., Youker K., Yu Q.T., Brugada R., DeMayo R, Quinones M, Roberts R. 1999. A transgenic rabbit model for human hypertrophic cardiomyopathy. J Clin. Invest., 104:1683-1692. (Pubitemid 30053185)
42. Massoud M., Attal J., Thepot D., Pointu H., Stinnakre M.G., Theron M C, Lopez C, Houdebine L.M. 1996. The deleterious effects of human erythropoietin gene driven by the rabbit whey acidic protein gene promoter in transgenic rabbits. Reprod. Nutr. Dev., 36: 555563.
43. Massoud M., Bischoff R., Dalemans W., Pointu H., Attal J., Schultz H., Clesse D, Stinnakre M.G., Pavirani A., Houdebine L.M. 1990. Production of human proteins in the blood of transgenic animals. C R Acad Sci Ser III Sci Vie., 311: 275-280. (Pubitemid 20338238)
44. Massoud M., Bischoff R., Dalemans W., Pointu H., Attal J., Schultz H., Clesse D., Stinnakre M.G., Pavirani A., Houdebine L.M. 1991. Expression of active recombinant human alpha 1-antitrypsin in transgenic rabbits. J. Biotechnol., 18:193-203.
45. McKee C, Gibson A., Dalrymple M., Emslie L., Garner I., Cottingham I. 1998. Production of biologically active salmon calcitonin in the milk of transgenic rabbits. Nat. Biotechnol, 16- 647-651.
46. Nishizawa T, Shen YT., Rossi F, Hong C, Robbins J., Ishikawa Y, Sadoshima J., Vatner D.E., Vatner SF. 2007. Altered autonomic control in conscious transgenic rabbits with overexpressed cardiac Gsalpha. Am. J. Physiol.-Heart Circul. Physiol., 292: H971-975.
47. Pattison J.S., Waggoner J.R., James J., Martin L., Gulick J., Osinska H., Klevitsky R., Kranias E.G., Robbins J. 2008. Phospholamban overexpression in transgenic rabbits. Transgenic Res., 17: 157-170. (Pubitemid 351421974)
48. Recalde D., Baroukh N., Viglietta C., Prince S., Verona J., Vergnes L., Pidoux J., Nanjee M.N., Brites R, Ochoa A, Castro G., Zakin M.M, Miller N.E., Houdebine L.M. 2004. Human apoA-I/C-III/AIV gene cluster transgenic rabbits: effects of a high-cholesterol diet. FEBS Lett. 572: 294-298. (Pubitemid 39092552)
49. Reigo E., Limonta J., Aguilar A., Perez A., de Armas R., Solano R., Ramos B., Castro F.O., de Ia Fuente J. 1993. Production of transgenic mice and rabbits that carry and express the human tissue plasminogen activator cDNA under the control of a bovine alpha S1 casein promoter. Theriogenology, 39: 1173-1185.
50. Rodriguez A, Castro FO., Aguilar A., Ramos B., Del Barco D.G., Lleonart R., De la Fuente J. 1995. Expression of active human erythropoietin in the mammary gland of lactating transgenic mice and rabbits. Biol Res., 28:141-153.
51. Rouy D., Duverger N., Lin S.D., Emmanuel F, Houdebine L.M., Denefie P, Viglietta C, Gong E, Rubin E.M., Hughes S.D. 1998. Apolipoprotein(a) yeast artificial chromosome transgenic rabbits. Lipoprotein(a) assembly with human and rabbit apolipoprotein B. J Biol. Chem., 273:1247-1251. (Pubitemid 28049228)
52. Sanbe A., James J., Tuzcu V, Nas S., Martin L., Gulick J., Osinska H., Sakthivel S., Klevitsky R., Ginsburg K.S., Bers D.M., Zinman B., Lakatta E.G., Robbins J. 2005. Transgenic rabbit model for human troponin I-based hypertrophic cardiomyopathy. Circulation, 111: 2330-2338. (Pubitemid 40647069)
53. Shen J., Kuhn H., Petho-Shramm A., Chan L. 1995. Transgenic rabbits with the integrated human 15-lipoxygenase gene driven by a lysozyme promoter: macrophage-specific expression and variable positional specificity of the transgenic enzyme. FASEB J., 9:16231631.
54. Soler E., Le Saux A., Guinut F., Passet B., Cohen R., Merle C, Charpilienne A., Fourgeux C., Sorel V., Piriou A., Schwartz-Cornil I, Cohen J., Houdebine L.M. 2005. Production of two vaccinating recombinant rotavirus proteins in the milk of transgenic rabbits. Transgenic Res., 14: 833-844. (Pubitemid 41706048)
55. Stromqvist M., Houdebine M., Andersson JO., Edlund A., Johansson T., Viglietta C., Puissant C., Hansson L. 1997. Recombinant human extracellular superoxide dismutase produced in milk of transgenic rabbits. Transgenic Res., 6: 271-278. (Pubitemid 27295538)
56. Taylor J.M., Fan J. 1997. Transgenic rabbit models for the study of atherosclerosis. Front. Biosci, 2: 298-308.
57. Wolf E., Jehle P.M., Weber M.M., Sauerwein H., Daxenberger A., Breier B.H., Besenfelder U., Frenyo L., Brem G. 1997. Human insulinlike growth factor I (IGF-I) produced in the mammary glands of transgenic rabbits: yield, receptor binding, mitogenic activity, and effects on IGF-binding proteins. Endocrinology, 138:307-313. (Pubitemid 27009438)
58. Yamanaka S., Balestra M.E., Ferrell L.D., Fan J., Arnold K.S., Taylor S., Taylor J.M., Innerarity TL. 1995. Apolipoprotein B mRNAediting protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl. Acad. Sci. U. S. A., 92, 8483-8487.
59. Zinovieva N., Lassnig C., Schams D., Besenfelder U., Wolf E., Muller S., Frenyo L., Seregi J., Muller M., Brem G. 1998. Stable production of human insulin-like growth factor 1 (IGF-I) in the milk of hemi- and homozygous transgenic rabbits over several generations. Transgenic Res., 7: 437-447. (Pubitemid 29188035)